Use of CoG by Patients With Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

July 16, 2018

Primary Completion Date

February 28, 2019

Study Completion Date

March 31, 2019

Conditions
Diabetes Mellitus
Interventions
DEVICE

non-invasive tissue glucose prediction

Generation of non-invasive and invasive glucose readings for comparison with a standard laboratory reference glucose determination method (YSI glucose analyzer)

Trial Locations (1)

94596

Mills-Penisnsula Medical Center, San Mateo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cnoga Medical Ltd.

INDUSTRY

lead

Sciema UG

OTHER

NCT03840161 - Use of CoG by Patients With Diabetes Mellitus | Biotech Hunter | Biotech Hunter